TLL1 variants do not predict hepatocellular carcinoma development in HCV cirrhotic patients treated with direct-acting antivirals

Elisabetta Degasperi, Enrico Galmozzi, Floriana Facchetti, Elisa Farina, Roberta D'Ambrosio, Roberta Soffredini, Massimo Iavarone, Pietro Lampertico

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'TLL1 variants do not predict hepatocellular carcinoma development in HCV cirrhotic patients treated with direct-acting antivirals'. Together they form a unique fingerprint.

Medicine & Life Sciences